Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study

Ju，Chunrong1; Lian，Qiaoyan1; Chen，Ao1; Xu，Xin1; Zhang，Jianheng1; Luo，Qun1; Huang，Danxia1; Chen，Rongchang2; He，Jianxing3

2022-09-01

10.55563/clinexprheumatol/hld9sf

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY   Impact Factor & Quartile

0392-856X

OBJECTIVES: The present study aimed to compare the post-lung transplant survival and complications of connective tissue disease (CTD)-related interstitial lung disease (ILD) and/or pulmonary arterial hypertension with idiopathic pulmonary fibrosis (IPF). METHODS: The clinical data of patients with CTD-ILD or IPF who received lung transplantation between 2015 and 2020 were retrospectively reviewed. Cumulative survival rates after transplantation were estimated using the Kaplan-Meier method. RESULTS: The study included 31 patients with confirmed CTD-ILD and 98 with IPF. Patients with CTD-ILD were significantly younger (53.2 ± 13.7 vs. 62.3 ± 7.2 years, p=0.001) and more likely female (61.3% vs. 7.1%, p<0.001) than patients with IPF. No significant difference was noticed in the 1-year and 5-year survival rates between CTD-ILD and IPF patients (1-year, 73.2% vs 71.4%, p=0.76; 5-year, 69.1% vs. 39.5%, p=0.21). The incidence of primary graft dysfunction was significantly higher in CTD-ILD patients (90.3% vs. 70.4%, p=0.03), while there was no significant difference in primary graft dysfunction-related mortality (6.5% vs. 6.1%, p=0.95) between the two groups. CONCLUSIONS: There was no significant difference in post-lung transplant survival and complications between CTD-ILD and IPF.

English

Others

CLINICAL MEDICINE

2-s2.0-85138457662

Scopus

1.First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,Guangzhou,China
2.Southern University of Science and Technology,Second Clinical Medical College of Jinan University,Shenzhen People's Hospital,Shenzhen Institute of Respiratory Diseases,Shenzhen,China
3.First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,Guangzhou,China

Ju，Chunrong,Lian，Qiaoyan,Chen，Ao,et al. Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY,2022,40(9):1666-1673.

Ju，Chunrong.,Lian，Qiaoyan.,Chen，Ao.,Xu，Xin.,Zhang，Jianheng.,...&He，Jianxing.(2022).Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY,40(9),1666-1673.

Ju，Chunrong,et al."Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study".CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 40.9(2022):1666-1673.